Medium materiality6/10
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
Trading thesisImportance 6/10
PHR likely volatile around Sept 2; upside if Q2 supports continued growth and guidance.
Signal detail
News insight
Source-backed analysis, the reasoning behind the signal, and its market context.
AI summary
What happened and why it matters
Phreesia will release fiscal Q2 2027 results after the Sept 2, 2026 close and hold a 5 PM ET conference call. The update underscores Phreesia's scale in patient activation, with 180 million visits in 2025 (about 1 in 6 U.S. visits). Expect near-term volatility as investors parse growth, margins and any guidance changes from the quarterly update.
- Sept 2, 2026: Q2 2027 results release after-market could trigger a gap move.
- 5 PM ET conference call next to the release is price-sensitive.
- No specific guidance provided in release; market focus on metrics and trajectory.
- Overall healthcare IT demand sentiment may influence Phreesia’s near-term direction.
Sentiment rationale
Without disclosed results or guidance in the release, immediate price reaction hinges on how the actual Q2 metrics compare to expectations and any forward guidance; historical moves around earnings in small/mid caps can be volatile but uncertain until numbers are released.
Key facts
- 01
Phreesia to report fiscal Q2 2027 results Sept 2 after-market.
- 02
Press release and stakeholder letter to be posted on ir.phreesia.com.
- 03
Conference call to discuss results at 5 PM ET on Sept 2.
- 04
Phreesia cites 180 million patient visits in 2025 (about 1 in 6 US visits).
Earnings
Category: Earnings. This is a scheduled quarterly results release with a post-close date and an investor call, typical for assessing growth trajectory and profitability; immediate price impact hinges on metrics and guidance specificity.
Related signals
More AI-analyzed coverage connected to this story